Cardlytics, Inc. (NASDAQ:CDLX) Insider Sells $10,772.63 in Stock

Cardlytics, Inc. (NASDAQ:CDLX) insider Nicholas Hollmeyer Lynton sold 3,377 shares of the business’s stock in a transaction dated Thursday, January 30th. The stock was sold at an average price of $3.19, for a total value of $10,772.63. Following the transaction, the insider now owns 94,706 shares of the company’s stock, valued at $302,112.14. The trade was a 3.44 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website.

Nicholas Hollmeyer Lynton also recently made the following trade(s):

• On Friday, January 3rd, Nicholas Hollmeyer Lynton sold 6,464 shares of Cardlytics stock. The stock was sold at an average price of $3.67, for a total value of $23,722.88.

Cardlytics Stock Performance

Shares of CDLX stock traded down $0.10 on Thursday, reaching $3.06. The stock had a trading volume of 687,561 shares, compared to its average volume of 1,027,198. Cardlytics, Inc. has a 12 month low of $2.76 and a 12 month high of $20.52. The company has a quick ratio of 1.18, a current ratio of 1.18 and a debt-to-equity ratio of 2.40. The firm has a market capitalization of $155.51 million, a price-to-earnings ratio of -0.50 and a beta of 1.53. The firm’s 50-day moving average is $3.64 and its two-hundred day moving average is $4.26.

Cardlytics (NASDAQ:CDLX) last announced its quarterly earnings results on Wednesday, November 6th. The company reported ($0.15) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.33) by $0.18. The business had revenue of $67.06 million during the quarter, compared to the consensus estimate of $57.77 million. Cardlytics had a negative return on equity of 110.67% and a negative net margin of 93.55%. The company’s quarterly revenue was down 15.1% on a year-over-year basis. During the same quarter last year, the firm posted ($0.26) EPS. On average, research analysts expect that Cardlytics, Inc. will post -1.52 EPS for the current fiscal year.

Institutional Investors Weigh In On Cardlytics

A number of institutional investors have recently made changes to their positions in CDLX. GSA Capital Partners LLP increased its position in Cardlytics by 1,273.2% during the third quarter. GSA Capital Partners LLP now owns 382,315 shares of the company’s stock worth $1,223,000 after acquiring an additional 354,474 shares during the period. RBF Capital LLC raised its stake in Cardlytics by 311.9% during the third quarter. RBF Capital LLC now owns 488,128 shares of the company’s stock worth $1,562,000 after acquiring an additional 369,620 shares in the last quarter. Geode Capital Management LLC lifted its stake in Cardlytics by 7.5% in the 3rd quarter. Geode Capital Management LLC now owns 1,053,178 shares of the company’s stock valued at $3,371,000 after purchasing an additional 73,484 shares during the last quarter. Barclays PLC lifted its stake in shares of Cardlytics by 223.9% in the 3rd quarter. Barclays PLC now owns 58,026 shares of the company’s stock valued at $186,000 after acquiring an additional 40,112 shares during the last quarter. Finally, SG Americas Securities LLC bought a new position in Cardlytics in the third quarter valued at about $45,000. Institutional investors own 68.10% of the company’s stock.

Wall Street Analysts Forecast Growth

CDLX has been the subject of several research analyst reports. Needham & Company LLC reiterated a “hold” rating on shares of Cardlytics in a report on Friday, January 17th. Craig Hallum upgraded Cardlytics from a “hold” rating to a “strong-buy” rating in a report on Wednesday, November 6th. Finally, Evercore ISI assumed coverage on Cardlytics in a research report on Friday, October 11th. They set an “in-line” rating and a $4.00 price objective for the company. One analyst has rated the stock with a sell rating, five have issued a hold rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average target price of $6.92.

Cardlytics Company Profile

Cardlytics, Inc operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing.